ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF

ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF

The present disclosure relates to isoxazolidines and their use as receptor-interacting protein kinase 1 inhibitors, for example in the treatment of diseases and disorders mediated by RIP kinase 1.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SZILLAT, Hauke, HEINELT, Uwe, RACKELMANN, Nils, MENDEZ-PEREZ, Maria, RITTER, Kurt, DEFOSSA, Elisabeth, ZECH, Gernot, MATTER, Hans
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SZILLAT, Hauke
HEINELT, Uwe
RACKELMANN, Nils
MENDEZ-PEREZ, Maria
RITTER, Kurt
DEFOSSA, Elisabeth
ZECH, Gernot
MATTER, Hans
description The present disclosure relates to isoxazolidines and their use as receptor-interacting protein kinase 1 inhibitors, for example in the treatment of diseases and disorders mediated by RIP kinase 1.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024109882A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024109882A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024109882A13</originalsourceid><addsrcrecordid>eNrjZDDyDPaPcIzy9_F08fRzDVZwDFYI8gzwNlTw9PPwdPIM8Q8Civm5KIQGuyqEeLgGufq78TCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-NBgIwMjE0MDSwsLI0dDY-JUAQAbtyfN</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF</title><source>esp@cenet</source><creator>SZILLAT, Hauke ; HEINELT, Uwe ; RACKELMANN, Nils ; MENDEZ-PEREZ, Maria ; RITTER, Kurt ; DEFOSSA, Elisabeth ; ZECH, Gernot ; MATTER, Hans</creator><creatorcontrib>SZILLAT, Hauke ; HEINELT, Uwe ; RACKELMANN, Nils ; MENDEZ-PEREZ, Maria ; RITTER, Kurt ; DEFOSSA, Elisabeth ; ZECH, Gernot ; MATTER, Hans</creatorcontrib><description>The present disclosure relates to isoxazolidines and their use as receptor-interacting protein kinase 1 inhibitors, for example in the treatment of diseases and disorders mediated by RIP kinase 1.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240404&amp;DB=EPODOC&amp;CC=US&amp;NR=2024109882A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240404&amp;DB=EPODOC&amp;CC=US&amp;NR=2024109882A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SZILLAT, Hauke</creatorcontrib><creatorcontrib>HEINELT, Uwe</creatorcontrib><creatorcontrib>RACKELMANN, Nils</creatorcontrib><creatorcontrib>MENDEZ-PEREZ, Maria</creatorcontrib><creatorcontrib>RITTER, Kurt</creatorcontrib><creatorcontrib>DEFOSSA, Elisabeth</creatorcontrib><creatorcontrib>ZECH, Gernot</creatorcontrib><creatorcontrib>MATTER, Hans</creatorcontrib><title>ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF</title><description>The present disclosure relates to isoxazolidines and their use as receptor-interacting protein kinase 1 inhibitors, for example in the treatment of diseases and disorders mediated by RIP kinase 1.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDyDPaPcIzy9_F08fRzDVZwDFYI8gzwNlTw9PPwdPIM8Q8Civm5KIQGuyqEeLgGufq78TCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-NBgIwMjE0MDSwsLI0dDY-JUAQAbtyfN</recordid><startdate>20240404</startdate><enddate>20240404</enddate><creator>SZILLAT, Hauke</creator><creator>HEINELT, Uwe</creator><creator>RACKELMANN, Nils</creator><creator>MENDEZ-PEREZ, Maria</creator><creator>RITTER, Kurt</creator><creator>DEFOSSA, Elisabeth</creator><creator>ZECH, Gernot</creator><creator>MATTER, Hans</creator><scope>EVB</scope></search><sort><creationdate>20240404</creationdate><title>ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF</title><author>SZILLAT, Hauke ; HEINELT, Uwe ; RACKELMANN, Nils ; MENDEZ-PEREZ, Maria ; RITTER, Kurt ; DEFOSSA, Elisabeth ; ZECH, Gernot ; MATTER, Hans</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024109882A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>SZILLAT, Hauke</creatorcontrib><creatorcontrib>HEINELT, Uwe</creatorcontrib><creatorcontrib>RACKELMANN, Nils</creatorcontrib><creatorcontrib>MENDEZ-PEREZ, Maria</creatorcontrib><creatorcontrib>RITTER, Kurt</creatorcontrib><creatorcontrib>DEFOSSA, Elisabeth</creatorcontrib><creatorcontrib>ZECH, Gernot</creatorcontrib><creatorcontrib>MATTER, Hans</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SZILLAT, Hauke</au><au>HEINELT, Uwe</au><au>RACKELMANN, Nils</au><au>MENDEZ-PEREZ, Maria</au><au>RITTER, Kurt</au><au>DEFOSSA, Elisabeth</au><au>ZECH, Gernot</au><au>MATTER, Hans</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF</title><date>2024-04-04</date><risdate>2024</risdate><abstract>The present disclosure relates to isoxazolidines and their use as receptor-interacting protein kinase 1 inhibitors, for example in the treatment of diseases and disorders mediated by RIP kinase 1.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2024109882A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T21%3A47%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SZILLAT,%20Hauke&rft.date=2024-04-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024109882A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true